IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Anthera Pharmaceuticals Inc (ANTH)

CUSIP: 03674U300 | NYSE | Healthcare · Biotechnology | Micro Cap | 70 institutional holders

Quarters

Q4 2025Q3 2025Q4 2019Q3 2018Q2 2018
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2025

Steigerwald, Gordon & Koch Inc.25
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Steigerwald, Gordon & Koch Inc.
25$00.0%ValueVery LowLeesburg, VA2026-01-23